av/cascades--big.svg

COM:CASCADES

Cascades

  • Stock

CAD

Last Close

11.15

22/11 21:00

Market Cap

903.34M

Beta: -

Volume Today

258.14K

Avg: -

Company Overview

Metric
Company NameCascades Inc.Apollo Endosurgery
SymbolCAS
MSH IDCOM:CASCADESCOM:APOLLOENDO
MarketSTOCKSPRIVATE
SectorConsumer CyclicalHealthcare & Health Services
IndustryPackaging & ContainersMedical Devices
CountryCAUS
StagePost-IPO Debt
Employee Count9.80K
Websitecascades.comapolloendo.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap638.89M
Enterprise Value
Monthly Web Traffic4.86K
Web Traffic Growth0.32
Valuation
Raised Capital35M

Financial Performance

Metric
Revenue3.28B
Revenue (LTM)
Revenue (NTM)
Gross Profit1.34B
EBITDA399.67M
Operating Income28.30M
Net Income-53.76M
EPS-0.54
Diluted EPS-0.54
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.41
Operating Profit Margin0.04
EBITDA Margin0.12
Net Profit Margin-0.00
Return on Equity-0.01
Return on Assets-0.00
Return on Capital Employed0.05

Valuation Multiples

Metric
P/E Ratio-46.55
P/B Ratio0.79
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.23
EV Multiple-1.52

Operational Metrics

Metric
Days Sales Outstanding44.26
Days Payables Outstanding120.26
Days Inventory Outstanding83.69
Operating Cycle121.67
Cash Conversion Cycle44.98
Asset Turnover0.97

Cash Flow Metrics

Metric
Operating Cash Flow360.76M
Free Cash Flow112.47M
Cash Flow to Debt0.26
Operating Cash Flow/Sales0.11
Free Cash Flow Yield-0.00

Balance Sheet Metrics

Metric
Cash & Equivalents38.20M
Accounts Receivable67.20M
Inventory401.79M
Goodwill340.25M
Debt to Capitalization0.53
Debt to Assets0.43
Current Ratio1.59
Quick Ratio0.63

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue-0.02
R&D to Revenue
SG&A to Revenue0.17